[1] 张之南, 沈悌. 血液病诊断及疗效标准 [M]. 3版. 北京: 科学出版社, 2007: 106-107.[2] Porcu P, Farag S, Marcucci G, et al. Leukocytoreduction for acute leukemia [J]. Ther Apher, 2002,6(1): 15-23.[3] Schwartz J, Winters J L, Padmanabhan A, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the Writing Committee of the American Society for Apheresis: the sixth special issue [J]. J Clin Apher, 2013, 28(3): 145-284.[4] De Santis G C, de Oliveira L C, Romano L G, et al. Therapeutic leukapheresis in patients with leukostasis secondary to acute myelogenous leukemia [J]. J Clin Apheresis, 2011, 26(4): 181-185.[5] Giles F J, Shen Y, Kantarjian H M, et al. Leukapheresis reduces early mortality in patients with acute myeloid leukemia with high white cell counts but does not improve long-term survival [J]. Leuk Lymphoma, 2001, 42(1-2): 67-73.[6] Bug G, Anargyrou K, Tonn T, et al. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis [J]. Transfusion, 2007, 47(10): 1843-1850.[7] Thiebaut A, Thomas X, Belhabri A, et al. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis [J]. Ann Hematol, 2000, 79(9): 501-506.[8] Porcu P, Danielson C F, Orazi A, et al. Therapeutic leukapheresis in hyperleucocytic leukaemias:lack of correlation between degree of cytoeducation and early mortality rate [J]. Br J Haematol, 1997, 98(2): 433-436.[9] Chang M C,Chen T Y, Tang J L, et al. Leukapheresis and cranial irradiation in patients with hyperleukocytic acute myeloid leukemia: no impact on early mortality and intracranial hemorrhage [J]. Am J Hematol, 2007, 82(11): 976-980.[10] Pastore F, Pastore A, Wittmann G, et al. The role of therapeutic leukapheresis in hyperleukocytotic AML [J]. Plos One, 2014, 9(4): e95062.[11] Oberoi S, Lehrnbecher T, Phillips B, et al. Leukapheresis and low-dose chemotherapy do not reduce early mortality in acute myeloid leukemia hyperleukocytosis: a systematic review and meta-analysis [J]. Leuk Res, 2014, 38(4): 460-468.[12] 陈惠仁. 血液科造血干细胞移植技术新进展与发展设想[J]. 解放军医药杂志,2013,25(4):1-5. |